Evidence map›Paper›PMID 41414851›Full record

ArticleJournal of applied clinical medical physics2026

Clinical validation of AI-assisted contouring in prostate radiation therapy treatment planning: Highlighting automation bias and the need for standardized quality assurance.

Najmeh Arjmandi, Ahmed Reza Sebzari, Fatemeh Molaei, Saeid Rezaei, Maryam Rezaie-Yazdi, Malihe Rezaie-Yazdi

Abstract readValidation Study
In one paragraph

Article in Journal of applied clinical medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Najmeh ArjmandiDepartment of Radiology, School of Paramedical Sciences, Gerash University of Medical Sciences, Gerash, Iran.
Ahmed Reza SebzariDepartment of Internal Medicine, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran.
Fatemeh MolaeiDepartment of Radiation Oncology, Iran Mehr Hospital, Birjand University of Medical Sciences, Birjand, Iran.
Saeid RezaeiRadiation Oncology Research Center, Cancer Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Maryam Rezaie-YazdiPhysics Unit, Department of Radiation Oncology, Iran Mehr Hospital, Birjand University of Medical Sciences, Birjand, Iran.
Malihe Rezaie-YazdiPhysics Unit, Department of Radiation Oncology, Iran Mehr Hospital, Birjand University of Medical Sciences, Birjand, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study evaluated the impact of a commercial AI-assisted contouring tool on intra- and inter-observer variability in prostate radiation therapy and assessed the dosimetric consequences of geometric contour differences.

methodsTwo experienced radiation oncologists independently delineated clinical target volume (CTV) and organs at risk (OARs) for prostate cancer patients. Manual contours (C

resultsAI-assisted contouring significantly improved both intra- and inter-observer agreement. Inter-observer analysis revealed that the Dice similarity coefficient (DSCs) for CTV increased from 0.78 (± 0.11) for C

conclusionAI-assisted contouring in prostate radiotherapy reduced intra- and inter-observer variability and improved contouring consistency. However, C

Indexed as

Artificial IntelligenceOrgans at RiskProstatic NeoplasmsQuality Assurance, Health CareRadiotherapy Planning, Computer-AssistedAutomationHumansMaleRadiotherapy DosageRadiotherapy, Intensity-ModulatedAuto‐contouringAutomation biasDeep learningInter‐observer variabilityIntra‐observer variabilityQuality assuranceRadiotherapy

Identifiers

PMID41414851
PMCPMC12715409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.